These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3375453

  • 1. Inhibition of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases by nonsteroidal anti-inflammatory drugs.
    Jarabak J.
    Prostaglandins; 1988 Mar; 35(3):403-11. PubMed ID: 3375453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.
    Jarabak J, Fried J.
    Prostaglandins; 1979 Aug; 18(2):241-6. PubMed ID: 42948
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of nicotinamide adenine dinucleotide- and nicotinamide adenine dinucleotide phosphate-linked 15-hydroxyprostaglandin dehydrogenases in placentas from normotensive and preeclamptic/eclamptic pregnancies.
    Jarabak J, Watkins JD, Lindheimer M.
    J Clin Invest; 1987 Oct; 80(4):936-40. PubMed ID: 3308960
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
    Cho H, Tai HH.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):461-5. PubMed ID: 12468268
    [Abstract] [Full Text] [Related]

  • 6. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue.
    Westbrook C, Lin YM, Jarabak J.
    Biochem Biophys Res Commun; 1977 Jun 06; 76(3):943-9. PubMed ID: 20082
    [No Abstract] [Full Text] [Related]

  • 7. Glutathione mixed disulfide inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.
    Chung H, Fried J, Williams-Ashman E, Jarabak J.
    Prostaglandins; 1987 Mar 06; 33(3):383-90. PubMed ID: 3575753
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies that inhibit the enzyme activity of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
    Tai CL, Mak OT, Arai T, Tai HH.
    Biochem J; 1990 Apr 01; 267(1):75-8. PubMed ID: 1691637
    [Abstract] [Full Text] [Related]

  • 9. Isolation of two proteins with 9-ketoprostaglandin reductase and NADP-linked 15-hydroxyprostaglandin dehydrogenase activities and studies on their inhibition.
    Lin YM, Jarabak J.
    Biochem Biophys Res Commun; 1978 Apr 28; 81(4):1227-34. PubMed ID: 666816
    [No Abstract] [Full Text] [Related]

  • 10. Early steps in prostaglandin metabolism in the human placenta.
    Jarabak J.
    Am J Obstet Gynecol; 1980 Nov 01; 138(5):534-40. PubMed ID: 6252782
    [Abstract] [Full Text] [Related]

  • 11. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
    Tai HH, Chi X, Tong M.
    Prostaglandins Other Lipid Mediat; 2011 Nov 01; 96(1-4):37-40. PubMed ID: 21763448
    [Abstract] [Full Text] [Related]

  • 12. NADP-dependent 15-hydroxyprostaglandin dehydrogenase is homologous to NAD-dependent 15-hydroxyprostaglandin dehydrogenase and other short-chain alcohol dehydrogenases.
    Wermuth B.
    Prostaglandins; 1992 Jul 01; 44(1):5-9. PubMed ID: 1641503
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.
    Quidville V, Segond N, Lausson S, Frenkian M, Cohen R, Jullienne A.
    Prostaglandins Other Lipid Mediat; 2006 Oct 01; 81(1-2):14-30. PubMed ID: 16997128
    [Abstract] [Full Text] [Related]

  • 15. Differences between 15-hydroxyprostaglandin dehydrogenase from pig placenta and human placenta [proceedings].
    Bradbear N, Jeffery J.
    Biochem Soc Trans; 1978 Oct 01; 6(6):1164-5. PubMed ID: 33855
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel prostaglandin dehydrogenase in rat skin.
    Fincham N, Camp R.
    Biochem J; 1983 Apr 15; 212(1):129-34. PubMed ID: 6575778
    [Abstract] [Full Text] [Related]

  • 18. Kinetic studies on 15-hydroxyprostaglandin dehydrogenase from human placenta.
    Schlegel W, Greep RO.
    Adv Prostaglandin Thromboxane Res; 1976 Apr 15; 1():159-62. PubMed ID: 187034
    [Abstract] [Full Text] [Related]

  • 19. Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
    Gobec S, Brozic P, Rizner TL.
    Bioorg Med Chem Lett; 2005 Dec 01; 15(23):5170-5. PubMed ID: 16183274
    [Abstract] [Full Text] [Related]

  • 20. Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase.
    Jarabak J.
    Arch Biochem Biophys; 1992 Jan 01; 292(1):239-43. PubMed ID: 1309294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.